We are live on ! Find out more
MAP

Madison Avenue Partners Portfolio holdings

AUM $2.3B
1-Year Est. Return 115.82%
This Fund
S&P 500
This Quarter Est. Return
+5.09%
1 Year Est. Return
+115.82%
3 Year Est. Return
+241.12%
5 Year Est. Return
+319.41%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
+$233M
Cap. Flow
+$207M
Cap. Flow %
17.55%
Top 10 Hldgs %
91.35%
Holding
23
New
8
Increased
4
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
MKL icon
Markel Group
MKL
+$168M
2
PCG icon
PG&E
PCG
+$48.9M
3
INDV icon
Indivior Pharmaceuticals
INDV
+$43.3M
4
SAGE
Sage Therapeutics
SAGE
+$32.8M
5
CMCO icon
Columbus McKinnon
CMCO
+$16.1M

Top Sells

Rank Stock Value
1
EDR
Endeavor Group Holdings, Inc.
EDR
+$75M
2
ACHC icon
Acadia Healthcare
ACHC
+$73M
3
NNI icon
Nelnet
NNI
+$6.31M
4
MAGN
Magnera Corp
MAGN
+$1.21M
5
SOLV icon
Solventum
SOLV
+$1.09M

Sector Composition

Rank Sector Weight
1 Healthcare 36.13%
2 Industrials 20.9%
3 Financials 16.7%
4 Communication Services 12.02%
5 Consumer Staples 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GHC icon
1
Graham Holdings Company
GHC
$4.97B
$236M 20.01%
245,271
+10,000
+4% +$9.31M
SOLV icon
2
Solventum
SOLV
$13.5B
$214M 18.16%
2,813,017
-14,655
-0.5% -$1.09M
MKL icon
3
Markel Group
MKL
$25B
$171M 14.5%
+91,357
New +$168M
WLY icon
4
John Wiley & Sons Class A
WLY
$2.52B
$98.4M 8.35%
2,208,066
+111,273
+5% +$4.7M
TBPH icon
5
Theravance Biopharma
TBPH
$874M
$84.9M 7.21%
9,511,150
– –
INDV icon
6
Indivior Pharmaceuticals
INDV
$4.79B
$74.3M 6.3%
7,792,089
+4,118,663
+112% +$43.3M
MAGN
7
Magnera Corp
MAGN
$488M
$60.7M 5.16%
3,344,005
-62,288
-2% -$1.21M
PCG icon
8
PG&E
PCG
$47.8B
$50.7M 4.3%
+2,950,000
New +$48.9M
INVX
9
Innovex International
INVX
$1.87B
$43.3M 3.68%
2,413,608
+727,132
+43% +$12.4M
STGW icon
10
Stagwell
STGW
$1.84B
$43.2M 3.67%
7,147,662
– –
SAGE
11
DELISTED
Sage Therapeutics
SAGE
$35.6M 3.02%
+4,477,798
New +$32.8M
NNI icon
12
Nelnet
NNI
$4.79B
$25.9M 2.2%
233,830
-56,383
-19% -$6.31M
CMCO icon
13
Columbus McKinnon
CMCO
$465M
$10.5M 0.89%
+619,343
New +$16.1M
SLRN
14
DELISTED
ACELYRIN
SLRN
$10.2M 0.87%
+4,142,640
New +$9.85M
CNNE icon
15
Cannae Holdings
CNNE
$647M
$7.68M 0.65%
+418,984
New +$7.9M
FSP
16
Franklin Street Properties
FSP
$44.8M
$4.87M 0.41%
2,733,418
– –
TSVT
17
DELISTED
2seventy bio
TSVT
$2.86M 0.24%
579,895
– –
PLRX icon
18
Pliant Therapeutics
PLRX
$67.5M
$2.26M 0.19%
+1,675,043
New +$10.2M
OVID icon
19
Ovid Therapeutics
OVID
$435M
$769K 0.07%
2,465,623
-1,257,004
-34% -$773K
SN icon
20
SharkNinja
SN
$21B
$513K 0.04%
6,152
– –
CRGX
21
DELISTED
CARGO Therapeutics
CRGX
$411K 0.03%
+100,952
New +$676K
ACHC icon
22
Acadia Healthcare
ACHC
$3.17B
$288K 0.02%
9,486
-1,915,841
-100% -$73M
EDR
23
DELISTED
Endeavor Group Holdings, Inc.
EDR
– –
-2,397,658
Closed -$75M

Similar funds

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
EPM
Elm Partners Management Philadelphia, Pennsylvania $2.31B AUM 16.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

Madison Avenue Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Madison Avenue Partners held 23 positions worth $1.18B, up 25% from $944M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Madison Avenue Partners deployed $207M of net new capital in Q1 2025, opening 8 new positions and adding to 4 existing holdings. Its largest new stake was Markel Group: 91,357 shares worth $171M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 43% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Acadia Healthcare, an estimated $73M trimmed.

  • Madison Avenue Partners's largest Q1 2025 buy was Markel Group: 91,357 shares worth $171M.
  • Madison Avenue Partners added most to Indivior Pharmaceuticals in Q1 2025, an estimated $43.3M increase.
  • Madison Avenue Partners's biggest Q1 2025 reduction was Acadia Healthcare, cutting an estimated $73M.
  • Madison Avenue Partners fully exited Endeavor Group Holdings, Inc. in Q1 2025, selling an estimated $75M.
  • Madison Avenue Partners's ten largest holdings make up 91% of its $1.18B portfolio in Q1 2025.
  • Madison Avenue Partners opened 8 new positions and closed 1 in Q1 2025.
  • Madison Avenue Partners's portfolio value rose 25% quarter-over-quarter to $1.18B.

Based on Madison Avenue Partners's 13F filing for Q1 2025, filed 15 May 2025.